New report sheds light on hospital price variation
Ever wonder why you can't get a straight answer about how much a test or procedure in the hospital? This new report has answers. More
Slow progress in reducing breast cancer overscreening
American women are still getting too many mammograms. Despite recommendations from the US Preventive Services Task Force and the American Cancer Society against routine screening for breast cancer before age 50, the rates of mammogram screening have not changed significantly in the past ten years. In a recent JAMA Clinical Update, Dr. Nancy Keating and […] More
When doing everything means doing less
For Randi Oster, the hardest part of her father's cancer wasn't getting him through treatment. It was getting his doctors to listen to what he wanted. More
The cart is driving the horse: Misguided performance measures
When it comes to measuring quality, there is a huge disconnect between payers and physicians. A recent analysis in the New England Journal of Medicine lends support to the physicians' side of the issue. More
Belief and evidence: How framing health news matters
Gina Kolata misrepresents the debate on tPA for strokes by painting the issue as evidence versus belief. More
Hidden influence: Financial conflicts you might have missed
Recent conflicts of interest in medicine and health policy you probably missed... More
Industry payments to doctors: Opioids are the tip of the iceberg
A closer look at the hundreds of millions that pharma spends on payments to physicians. More
Industry payments to doctors: Opioids are the tip of the iceberg
A closer look at the hundreds of millions that pharma spends on payments to physicians. More
Meeting people where they are for primary care
How can we increase access to primary care in underserved areas? How about meeting patients where they are? More
What we know and don’t know about overdiagnosis
A study in The BMJ shows that overdiagnosis research is growing but discrepancies in definitions and measurement complicate the evidence. More
What’s the harm in excessive cancer screening?
Not only does too much cancer screening lead to false positives and overtreatment, it can also skew our data. More
As dangerous as opioids: Benzo overprescription becoming a crisis
Opioids aren't the only drug being dangerously overprescribed... More
New blood pressure guidelines increases danger of overtreatment
Why the new lower blood pressure target could be harmful to patients... More
Value-based care initiatives floundering in a broken system
Does value-based care stand a chance against the fee-for-service Goliath? More
Health care? More like health scare!
Every day is Halloween for pharma marketers... More
Why is pediatric overuse being overlooked?
Medical overuse is just as much a problem in children's health care as it is for adults, so why isn't there more recognition of this issue? More
Maryland’s all-payer system shows hospitals can live within their means
Fee-for-service drives overuse and high costs, but what's the alternative? Maryland may have the answer. More
Conflicts of interest complicate Hep C research debate
Researchers and advocates are up in arms over a new review of Hepatitis C treatments. But look who's funding each side... More
Why corruption is the new normal in health care (and what we can do about it)
From industry payments to kickbacks, corruption is everywhere in health care. And it comes at a high cost to patient safety. More
An Interview with Patty Gabow
An Interview with Patty Gabow Keeping the Patient at the Center in Hospital Administration Patricia A. Gabow, MD, MACP is Professor Emerita of Medicine at the University of Colorado and the former CEO of Denver Health. She is the author of more than 130 articles, 36 books and book chapters, and a recent book, The Lean Prescription: Powerful […] More